Dr. Darin Takeo Okuda, MD

Dr. Okuda practices at James W Aston Ambulatory Care Center in Dallas, Texas.

Dr. Okuda's NPI, 1043255722, was assigned on June 18, 2006. Dr. Okuda graduated from John A. Burns School of Medicine in 2000. Dr. Okuda holds Texas license P6483.

Dr. Okuda's primary practice is James W Aston Ambulatory Care Center, at 5303 Harry Hines Blvd, Dallas, TX 75390 in Dallas County. The practice phone is (214) 645-2300.

Dr. Okuda's primary practice is James W Aston Ambulatory Care Center in Dallas, Texas. Dr. Okuda is also affiliated with William P. Clements Jr. University Hospital. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Dr. Okuda to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Okuda practices, 2 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Okuda's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Okuda is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Okuda's licenses on file in 3 states: Texas, Arizona and California.

Dmand AI lists multiple sclerosis among the conditions Dr. Okuda treats.

CMS data shows 98 Medicare services from Dr. Okuda across 2 procedure codes in 2024, for 73 Medicare patients. Medicare paid $6,050 for them. Every service was in an office.

CMS counts 73 Medicare patients who saw Dr. Okuda in 2024. The largest group is 65 to 74, with 36 patients. 60% of them have high cholesterol, and 56% have high blood pressure. Their average risk score is 1.23, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Okuda's median patient age at 49, with 75% women.

In 2024, Dr. Okuda wrote 346 Medicare Part D claims for 76 patients. 83% of them were for generic drugs. CMS names the drug for 207 of them, across 10 drugs with 11 or more claims each, at $347,208 in total drug cost. In 2023, CMS named 258 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Okuda for performance year 2024, reported as part of a group. Dr. Okuda accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Okuda as offering telehealth.

Dmand AI links 68 papers to Dr. Okuda, published from 2009 to 2025. 2024 was the busiest year, with 12. The most frequent topics are Multiple Sclerosis, Magnetic Resonance Imaging and Brain. Dr. Okuda has published most often in Mult Scler Relat Disord. Dr. Okuda's most frequent co-authors are Orhun H. Kantarci, MD, Elliot Mark Frohman, MD, PhD and Shanan Brinson Munoz, MD.

Dmand AI links Dr. Okuda to 2 clinical trials. Conditions studied include Multiple Sclerosis and Demyelinating Autoimmune Diseases, CNS.

CMS Open Payments shows 1,092 general payments to Dr. Okuda from 25 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 45% of the total. Sanofi and Genzyme US Companies paid the most, $605,216. It also lists 3 research payments totaling $4,226 from 2017 to 2023.

Dmand AI lists 1 award for Dr. Okuda, most recently CMS Stage 1 EHR in 2013.

Dr. Okuda graduated from John A. Burns School of Medicine in 2000.

Dr. Okuda is in network with 21 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.